Arcus Biosciences (RCUS) EBITDA Margin (2017 - 2026)
Arcus Biosciences' EBITDA Margin was -226.83% in Q2 2026, down 223.08 percentage points from -3.75% a year earlier but up 549.64 percentage points from the prior quarter.
Powered by 
Analysis
Arcus Biosciences (RCUS) EBITDA Margin (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Arcus Biosciences' EBITDA Margin was -406.84% through Jun 30, 2026, down 281.65 percentage points year-over-year; for FY2025, it came in at -152.23%, down 28.20 percentage points from FY2024.
- EBITDA Margin shows a five-year change of +2.90 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was -124.03% in FY2024 (+159.73 pp), -283.76% in FY2023 (-39.12 pp), -244.64% in FY2022 (-259.79 pp) and 15.14% in FY2021 (+170.27 pp).
- Quarterly EBITDA Margin has moved between -815.70% (Q3 2021) and 79.65% (Q4 2021) over five years.
- Compared with a year earlier, EBITDA Margin was higher in three of the last eight quarters, with an average year-over-year change of -133.97 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q4 2021 (a gain of 618.78 percentage points); the worst was Q3 2021 (a drop of 819.25 percentage points).
- Per Business Quant data, RCUS's EBITDA Margin in the three quarters before Q2 2026 was -776.47% (Q1 2026), -336.36% (Q4 2025) and -538.46% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Arcus Biosciences | 3.18 Bn | -157.19 Mn | - | -226.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -226.83% |
| Mar 31, 2026 | -776.47% |
| Dec 31, 2025 | -336.36% |
| Sep 30, 2025 | -538.46% |
| Jun 30, 2025 | -3.75% |
| Mar 31, 2025 | -425.00% |
| Dec 31, 2024 | -384.62% |
| Sep 30, 2024 | -214.58% |
| Jun 30, 2024 | -266.67% |
| Mar 31, 2024 | -8.97% |
| Dec 31, 2023 | -283.87% |
| Sep 30, 2023 | -246.88% |
| Jun 30, 2023 | -279.31% |
| Mar 31, 2023 | -336.00% |
| Dec 31, 2022 | -214.71% |
| Sep 30, 2022 | -206.06% |
| Jun 30, 2022 | -248.15% |
| Mar 31, 2022 | -366.67% |
| Dec 31, 2021 | 79.65% |
| Sep 30, 2021 | -815.70% |
API Access
Arcus Biosciences EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();